The ADGRG1 gene plays a crucial role in the development of the cerebral cortex, and mutations in this gene have been associated with polymicrogyria, a condition characterized by abnormal development of the brain leading to numerous small folds on the cerebral surface. This condition, particularly affecting the bilateral frontoparietal regions, can result in a range of neurological problems, including developmental delays, seizures, and difficulties with coordination and speech.
To identify mutations in the ADGRG1 gene that may lead to polymicrogyria, a specialized genetic test is available at DNA Labs UAE. This test involves analyzing the patient's DNA to look for specific mutations in the ADGRG1 gene that are known to cause the condition. The test is crucial for accurate diagnosis, which can help in managing the symptoms through targeted therapies and interventions.
The cost of the ADGRG1 gene polymicrogyria bilateral frontoparietal genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis necessary to detect the genetic markers associated with the condition, offering invaluable information for affected individuals and their families. It is an essential tool for those seeking answers to complex neurological conditions, enabling a pathway towards better understanding and management of polymicrogyria.
The NR2E1 Gene Polymicrogyria Bilateral Occipital Genetic Test is a specialized diagnostic tool used to identify mutations in the NR2E1 gene, which have been associated with bilateral occipital polymicrogyria, a rare neurological condition. This condition is characterized by an excessive number of small and irregularly formed gyri in the occipital lobes of the brain, which can lead to a range of neurological symptoms, including developmental delays, seizures, and visual impairments.
The test involves analyzing the patient's DNA to detect any genetic variations in the NR2E1 gene that may be indicative of this condition. It is a crucial step for families seeking answers to developmental and neurological issues in their loved ones, as a positive identification of a mutation can guide treatment plans, inform about prognosis, and offer insights into the risk of recurrence in future pregnancies.
Performed at DNA Labs UAE, a leading facility in genetic testing and analysis, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify and interpret genetic mutations associated with bilateral occipital polymicrogyria. Families and individuals undergoing this test at DNA Labs UAE can expect comprehensive support, from pre-test counseling to understand the implications of the test results, to post-test guidance to navigate the next steps in managing the condition.
The "TUBA8 Gene Polymicrogyria with Optic Nerve Hypoplasia Genetic Test" is a specialized diagnostic procedure available at DNA Labs UAE. Priced at 4400 AED, this test is designed to identify mutations in the TUBA8 gene, which have been linked to the development of polymicrogyria, a condition characterized by abnormal development of the brain leading to numerous small folds on the surface of the brain, and optic nerve hypoplasia, a congenital issue where the optic nerve is underdeveloped. These conditions can lead to a range of neurological problems and visual impairments.
The test involves the collection of a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab for the presence of specific genetic mutations in the TUBA8 gene. Results from this test can provide crucial information for the diagnosis, treatment planning, and genetic counseling for affected individuals and their families. By understanding the genetic underpinnings of these conditions, healthcare providers can offer more targeted and effective care, and families can gain insights into the hereditary nature of the disorders, potential risks for future children, and connect with appropriate support and resources.
The PI4KA Gene Polymicrogyria Perisylvian with Cerebellar Hypoplasia and Arthrogryposis Genetic Test is a specialized diagnostic examination conducted to identify mutations in the PI4KA gene. This gene is associated with a complex neurological condition that encompasses a spectrum of symptoms including polymicrogyria, particularly around the sylvian fissure, cerebellar hypoplasia, and arthrogryposis. Polymicrogyria is a condition characterized by abnormal development of the brain leading to numerous small folds on the cerebral surface. Cerebellar hypoplasia refers to underdevelopment of the cerebellum, a region of the brain that plays an essential role in motor control. Arthrogryposis involves joint contractures that are present at birth.
This genetic test is crucial for the accurate diagnosis and understanding of the condition's severity and potential progression. It aids in tailoring specific therapeutic interventions and supports genetic counseling for affected families. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is 4400 AED, reflecting the sophisticated nature of the genetic analysis and the specialized expertise required to interpret the results. This test is an invaluable tool for clinicians and families seeking to navigate the complexities of this rare genetic disorder, offering insights that can significantly impact management and care strategies.
The IRF6 gene plays a crucial role in the development and function of tissues and organs in the body, particularly in the facial, skin, and genital areas. Mutations in the IRF6 gene can lead to Popliteal Pterygium Syndrome Type 1 (PPS1), a rare genetic disorder characterized by webbing of the skin behind the knees (popliteal pterygium), oral clefts, lip pits, genital malformations, and, in some cases, anomalies in the limbs and nails.
To diagnose PPS1, a genetic test focusing on the IRF6 gene can be conducted. This test identifies mutations in the IRF6 gene that are responsible for the syndrome, providing crucial information for diagnosis, treatment planning, and genetic counseling.
In the United Arab Emirates, DNA Labs UAE offers this specific genetic test. The cost of the test is 4400 AED. Conducted in a state-of-the-art facility, the test is designed to provide accurate and reliable results, assisting in the early detection and management of Popliteal Pterygium Syndrome Type 1. This genetic testing is an essential tool for families with a history of PPS1, offering insights into the condition and aiding in making informed decisions regarding healthcare and family planning.
The RIPK4 Gene Popliteal Pterygium Syndrome Lethal Type Genetic Test is a specialized diagnostic procedure designed to identify mutations in the RIPK4 gene, which are linked to the lethal type of Popliteal Pterygium Syndrome (PPS). This rare genetic disorder is characterized by skin webbing across the joints, cleft lip and/or palate, genital anomalies, and in its lethal form, can include more severe manifestations leading to neonatal mortality. The test is crucial for expecting parents with a family history of the condition or for newborns showing symptoms indicative of PPS.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, usually through a blood draw or buccal swab, and analyzing it for specific mutations in the RIPK4 gene. The outcome of this test not only aids in confirming the diagnosis but also helps in guiding clinical management and genetic counseling for affected families.
The cost of the RIPK4 Gene Popliteal Pterygium Syndrome Lethal Type Genetic Test is set at 4400 AED. Given the complexity of the condition and the specialized technology required for genetic analysis, this price reflects the extensive resources involved in providing accurate and reliable results. For families facing the possibility of this condition, the test offers invaluable information for making informed health and reproductive decisions.
The COL4A1 gene plays a crucial role in the development and maintenance of the brain's blood vessels. Mutations in this gene can lead to a rare neurological disorder known as porencephaly, which is characterized by the presence of cysts or cavities within the brain. These abnormalities can lead to a range of symptoms, including developmental delays, seizures, and cerebral palsy, depending on the severity and location of the cysts.
Familial genetic testing for mutations in the COL4A1 gene is essential for families with a history of porencephaly, as it can provide valuable information for understanding the risk of the disorder being passed to future generations. This genetic test can also be beneficial for early diagnosis and management in families where the genetic mutation is present.
In the United Arab Emirates, DNA Labs UAE offers a specialized genetic test to identify mutations in the COL4A1 gene. The cost of this test is 4400 AED. This testing facility provides a comprehensive service, including the collection of a DNA sample, usually through a blood draw or cheek swab, and detailed analysis in their state-of-the-art laboratory. The results from this test can help guide families and their healthcare providers in making informed decisions about care and management for individuals who may be affected by porencephaly.
The LAMA1 Gene Poretti-Boltshauser Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the LAMA1 gene, which are associated with Poretti-Boltshauser Syndrome (PBS). PBS is a rare genetic disorder characterized by cerebellar ataxia, abnormalities in eye movement, and distinctive changes in the structure of the brain, particularly the cerebellum. These mutations are inherited in an autosomal recessive pattern, meaning both copies of the gene in each cell have mutations for the disease to manifest.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any abnormalities or mutations in the LAMA1 gene that could indicate the presence of Poretti-Boltshauser Syndrome.
The cost of the LAMA1 Gene Poretti-Boltshauser Syndrome Genetic Test at DNA Labs UAE is set at 4400 AED. This price may encompass the full service from sample collection, analysis, and provision of a comprehensive report that interprets the results in a context that is understandable to both healthcare professionals and the patient. This test is crucial for families with a history of PBS, as early diagnosis can aid in managing symptoms and improving the quality of life for affected individuals.
The DHODH Gene Postaxial Acrofacial Dysostosis Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, aimed at detecting mutations in the DHODH gene. These mutations are associated with Postaxial Acrofacial Dysostosis (PAFD), a rare genetic disorder characterized by craniofacial, limb, and dental anomalies. The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two altered copies of the DHODH gene, one from each parent, to be affected.
The test is crucial for accurate diagnosis and management of the condition, enabling healthcare providers to offer personalized care plans and genetic counseling to affected families. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the DHODH gene.
The cost of the DHODH Gene Postaxial Acrofacial Dysostosis Genetic Test at DNA Labs UAE is 4400 AED. This cost includes the full process of sample collection, genetic analysis, and a comprehensive report detailing the findings. Patients and families considering this test are encouraged to consult with a genetic counselor or healthcare provider to discuss its implications, benefits, and any potential next steps based on the results.
The PEPD Gene Prolidase Deficiency Genetic Test is a specialized diagnostic procedure designed to identify mutations in the PEPD gene, which are responsible for a rare metabolic disorder known as prolidase deficiency. This condition is characterized by the body's inability to break down certain proteins properly, leading to a spectrum of symptoms including skin lesions, recurrent infections, and impaired physical development. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test provides a comprehensive analysis of the PEPD gene to detect any abnormalities or mutations. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then examined using advanced genetic sequencing technologies. This enables precise identification of mutations that may lead to prolidase deficiency.
The cost of the PEPD Gene Prolidase Deficiency Genetic Test at DNA Labs UAE is set at 4400 AED. While the price may seem steep, it reflects the intricate technology and expertise required to accurately diagnose this rare genetic disorder. For families and individuals facing the possibility of prolidase deficiency, this test offers a critical pathway towards understanding their condition and accessing appropriate treatments and interventions.
